(Press-News.org) However, large-scale clinical trials have highlighted the beneficial effect of cardiac resynchronisation therapy (CRT) in the improvement of symptoms and reduction of mortality, and CRT is now recommended in the major European and American guidelines for the treatment and prevention of heart failure.(1)
Clinical trials, however, are performed in carefully selected subjects and their results are not always applicable to the general population. Large-scale registries or surveys, on the other hand, capture data from a much more heterogeneous population and are closer to everyday clinical practice (although the applicability of the sample may be a concern).
Now, the European CRT Survey, whose follow-up results are published today in the European Journal of Heart Failure, suggests that CRT does indeed reduce rates of death and re-hospitalisation among heart failure patients.(2) Indeed, at one-year follow-up most patients who had received a CRT device considered their symptoms were better than their pre-implant assessment.(3)
The survey - a joint initiative of the Heart Failure Association and European Heart Rhythm Association of the European Society of Cardiology (ESC) - gathered information on more than 2000 patients at 141 centres in 13 European countries. Its aim was to assess the effect of CRT on symptom severity, cardiovascular re-hospitalisation, and survival. The study population included subjects poorly represented in clinical trials but commonly admitted as heart failure patients - including the very elderly, those with atrial fibrillation, and those previously treated with a pacemaker or other cardiac device.
Analysis of the survey data showed that at, one year (average) follow-up, 81% reported a self-assessed improvement in their symptoms (with 16% no change and 4% a deterioration).
The survey also found that almost 25% of the subjects had died or been re-hospitalised within the 12-month follow-up period. This poor outcome (whose rate is consistent with that found in clinical trials - was directly associated with the diagnostic severity of the heart failure, the pre-existence of atrial fibrillation (or other heart disease), and the type of resynchronisation cardiac device implanted. Patients implanted with a pacing device only (CRT-P) had higher rates of mortality than those whose device had an additional defibrillator (CRT-D).
First author Dr Nigussie Bogale from Stavanger University Hospital in Norway said: "This is the largest study reporting a difference in outcome between CRT-D and CRT-P. Most patients with an indication for CRT have also an indication for a defibrillator. So unless they have contraindicating co-morbidities, it is now our belief that these patients should be considered for CRT-D implantation."
The use of advanced CRT devices has gained increasing acceptance in recent years and they are now being implanted on a large scale as an adjunct to conventional drug treatment. Indeed, some reports have described the two types of devices (CRT-P and CRT-D) as a revolution in heart failure. One important study cited in the most recent guidelines on heart failure suggested implantation of an ICD was associated with a 23% reduction in all-cause mortality.(4)
One study reporting in 2009 found that throughout 15 European countries the number of CRT implantations increased substantially, from 46/million in 2004 to 99/million in 2008, an increase of 115%. This was mainly explained by an increase in use of CRT-D devices. One study cited by many recent guidelines (MADIT-CRT) found that CRT-D decreased the risk of heart-failure events even in relatively asymptomatic patients (with a 34% reduction in the risk of all-cause mortality or heart failure).(5) This European CRT Survey now suggests that benefits of this nature - in both symptoms and survival - can be replicated in routine everyday practice.
However, despite the benefits and the recommendations, other studies show there is still a wide gap between those who meet the criteria for CRT and those who actually have a device implanted.
###
Notes to editor
(1) Cardiac resynchronisation pacemakers (CRT-P) and defibrillators (CRT-D) for treating heart failure, which have evolved from conventional pacemakers, aim to correct abnormal contractions of the heart's ventricles. More than half of the mortality associated with heart failure is because of sudden cardiac death - and the most important predictor of SCD is left ventricular dysfunction, the underlying cause of heart failure. The use of CRT aims to correct dyssynchrony and prevent sudden cardiac death.
(2) Bogale N, Priori S, Cleland JGF, et al. The European CRT Survey: 1 year (9-15 months) follow-up results. Eur J Heart Fail 2011; doi:10.1093/eurjhf/hfr158.
(3) The main symptoms of heart failure are breathlessness (dyspnoea), tiredness and weakness, and oedema (swelling in the legs and ankles).
(4) Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
(5) Van Veldhuisen DJ, Maass AH, Priori SG, et al. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009; doi:10.1093/eurjhf/hfp149.
* The European Journal of Heart Failure is a journal of the European Society of Cardiology.
* Heart failure is by far the single biggest reason for acute hospital admission. Around 30 million people in Europe have heart failure and its incidence is still increasing: more cases are being identified, more people are living to an old age, and more are surviving a heart attack but with damage to the heart muscle.
The 2010 Focused Update of ESC Guidelines on device therapy in heart failure can be seen in various formats
More information on this press release and a PDF of the paper is available from the ESC's press office
press@escardio.org
With the share of married adults at an all-time low in the United States, new research by demographers at Cornell University and the University of Central Oklahoma unveils clues why couples don't get married – they fear divorce.
Among cohabitating couples, more than two-thirds of the study's respondents admitted to concerns about dealing with the social, legal, emotional and economic consequences of a possible divorce.
The study, "The Specter of Divorce: Views from Working and Middle-Class Cohabitors," is published in the journal Family Relations (December 2011) and ...
In an example of life imitating art, biologists and bioengineers at UC San Diego have created a living neon sign composed of millions of bacterial cells that periodically fluoresce in unison like blinking light bulbs.
Their achievement, detailed in this week's advance online issue of the journal Nature, involved attaching a fluorescent protein to the biological clocks of the bacteria, synchronizing the clocks of the thousands of bacteria within a colony, then synchronizing thousands of the blinking bacterial colonies to glow on and off in unison.
A little bit of art with ...
Timeshare and fractional companies planning to enter the Perspective Magazine Awards Program, sponsored by Holiday Systems International, only have until the end of this week to submit their entries and become part of the most comprehensive, global awards program of its kind in the industry. Winners will be announced at the conclusion of the Global Networking Expo, GNEX 2012 - A Global Meeting of Minds, in Cancun, Mexico.
Perspective Magazine ( http://perspectivemagazine.com ) created the awards program, with its exclusive online voting system, to allow companies from ...
Inner Mongolia and Shenzhen, China – Inner Mongolia Agricultural University (IMAU), Inner Mongolia University for the Nationalities (IMUN) and BGI, the world's largest genomics organization, jointly announced the first complete sequencing of Mongolian genome. This genomic study will help researchers to better understand the evolutionary process and migration of Mongolians and their ancestors from Africa to Asia, which also lays an important genomic foundation for further development of human genetic diseases research.
Nowadays, Mongol is a central Asian ethnic group mostly ...
Stabilizing the cell's power-generating center protects against Parkinson's disease (PD) in a rat model, according to a report published online this week in the Journal of Experimental Medicine (www.jem.org).
Mitochondria—the energy production center of cells—are damaged in PD, leading to loss of dopaminergic neurons and degeneration of brain function. Taking advantage of the fact that viruses often stabilize mitochondria in order to ensure survival of the cells they infect, a team led by John Sinclair and Roger Barker at the University of Cambridge injected a viral ...
The Doubletree Hotel in Grand Junction will be the venue for a Saturday, January 14, 2012 Bridal Fair produced by CUMULUS Radio. Moab Utah Travel Council cojoin wedding businesses in a booth for Moab Destination Weddings. Thus far a sample of wedding services will be at the booth to describe Moab for outdoor wedding ceremonies, highlight reception venues, local wedding planner capabilities, full wedding destination services like wedding cakes and relaxation treatments.
Moab Utah is home to Canyonlands and Arches National Parks. A National Park wedding venue is not the ...
A simple physician notification system can help prevent further fractures in osteoporotic patients who have had already had fractures, according to a study in CMAJ (Canadian Medical Association Journal).
Patients who have had a major fracture because of osteoporosis do not undergo testing for bone mineral density or receive medications to help prevent additional fractures. Recent 2010 Canadian clinical practice guidelines for osteoporosis care noted this "care gap" for patients at risk of additional fractures.
Researchers from the University of Manitoba and Manitoba ...
Mel Campbell, president and founder of Campbell, Harrington & Brear Advertising Agency, of York, has been invited to serve as one of three judges for the AAF-Coastal Carolinas ADDY Awards competition in Myrtle Beach, SC, in January of 2012.
Campbell will help to select the most outstanding of 150-plus entries for the local ADDY Awards competition (covering Florence, Georgetown and Myrtle Beach, South Carolina and Wilmington, North Carolina), the first of a three-tier, national competition conducted annually by the American Advertising Federation (AAF).
The AAF ...
STANFORD, Calif. -- Stanford University School of Medicine investigators have shown that iPS cells, viewed as a possible alternative to human embryonic stem cells, can mirror the defining defects of a genetic condition — in this instance, Marfan syndrome — as well as embryonic stem cells can. An immediate implication is that iPS cells could be used to examine the molecular aspects of Marfan on a personalized basis. Embryonic stem cells, on the other hand, can't do this because their genetic contents are those of the donated embryo, not the patient's.
This proof-of-principle ...
Routine criminal prosecutions for not disclosing HIV status should be abolished, write three HIV/AIDS experts in an article in CMAJ (Canadian Medical Association Journal).
"In Canada, despite remarkable medical advances that have made HIV/AIDS a manageable illness, recent years have seen an escalation in the number of people prosecuted for allegedly exposing sexual partners to the virus," write M-J Milloy, Thomas Kerr and Julio Montaner of the British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, BC. "An upcoming case being heard in February ...
